Q21.12
Q21.12: Patent foramen ovale
Billable / specific codeICD-10-CMPOA exempt
Q21.12 is a billable, specific ICD-10-CM code for patent foramen ovale. It is valid for submission on a claim.
Check Q21.12 with the rest of the claim: free scrubberInclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Persistent foramen ovale
Excludes1 inherited from the categories above Q21.12
A category’s note binds every code beneath it.
Excludes2 inherited from the categories above Q21.12
Not part of this code, but both may be coded when both are present.
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
Q21.12 is named in 19 Medicare coverage policies: 19 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52850Billing and Coding: Cardiac Catheterization and Coronary Angiography
- A52868Billing and Coding: Transesophageal Echocardiography (TEE)
- A54111Billing and Coding: Speech Language Pathology (SLP) Services: Communication Disorders
- A56451Billing and Coding: Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
Alphabetic index entries that lead here
- Foramen ovale(nonclosure) (patent) (persistent)
- Closure›foramen ovale, imperfect
- Anomaly, anomalous›foramen›Botalli
- Anomaly, anomalous›foramen›ovale
- Cyanosis›due to›patent foramen botalli
- Cyanosis›due to›persistent foramen ovale
- Nonclosure›foramen›botalli
- Nonclosure›foramen›ovale
- Patent›foramen›botalli
- Patent›foramen›ovale
- Persistence, persistent›foramen›Botalli
- Persistence, persistent›foramen›ovale
Code history
Unchanged in every release from FY2024 to FY2027.
Other codes under Q21.1
- Q21.10Atrial septal defect, unspecified
- Q21.11Secundum atrial septal defect
- Q21.13Coronary sinus atrial septal defect
- Q21.14Superior sinus venosus atrial septal defect
- Q21.15Inferior sinus venosus atrial septal defect
- Q21.16Sinus venosus atrial septal defect, unspecified
- Q21.19Other specified atrial septal defect